New Triple Therapy for Chronic Hepatitis C: Real Life Clinical Experience in a Community Setting

Recent advances in treatment of chronic hepatitis C virus have improved significantly due to the introduction of two new protease inhibitors—telaprevir and boceprevir. In combination with the previous standard of care, peginterferon and ribavirin, telaprevir and boceprevir have demonstrated improved...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Akiyama, Matthew J, Piotrowski, Joy I, Roytman, Marina M, Chan, Siu MA, Hong, Leena K, Huddleston, Leslie, Trujillo, Ruby, Tsai, Naoky CS
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: University Clinical, Education & Research Associate (UCERA) 2013
Pynciau:
American College of Physicians, Hawai‘i Chapter; Annual Meeting 2013
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764547/
https://ncbi.nlm.nih.gov/pubmed/24052911
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg